Methods For Predicting Irinotecan Toxicity

Abstract

The present invention concerns the methods and compositions for evaluating the risk of ironotecan toxicity in a cancer patient based on the genotype of the patient at position −3156 of the UGT1A1 gene or at any position in linkage disequilibrium with the −3156 variant.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 5, 2010
  • Application: May 28, 2004
    US US 55851004 A
  • Priority: May 28, 2004
    US US 2004/0016920 W
  • Priority: May 30, 2003
    US US 47482603 P

Sign in to the Lens

Feedback